motor complications And NotOlivier Rascol
List of bibliographic references
Number of relevant bibliographic references: 16.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000260 | Rebecca Stowe [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Kelly Handley [Royaume-Uni] ; Alexandra Furmston [Royaume-Uni] ; Katherine Deane [Royaume-Uni] ; J. J. Van Hilten [Pays-Bas] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Meta‐analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease |
| 000363 | Stephanie M. Van Rooden [Pays-Bas] ; Fabrice Colas [Pays-Bas] ; Pablo Martínez-Martín [Espagne] ; Martine Visser [Pays-Bas] ; Dagmar Verbaan [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Ray K. Chaudhuri [Royaume-Uni] ; Joost N. Kok [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] | Clinical subtypes of Parkinson's disease |
| 000638 | Iria Cabo L Pez [Espagne] ; Pedro J. García Ruiz [Espagne] ; Silvia Vázquez Fernández Del Pozo [Espagne] ; Vicenta Sánchez Bernardos [Espagne] | Motor complications in Parkinson's disease: Ten year follow‐up study |
| 000A25 | Sebastian Paus [Allemagne] ; Franziska Gadow [Allemagne] ; Michael Knapp [Allemagne] ; Christine Klein [Allemagne] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne] | Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism |
| 000D61 | C. Warren Olanow [États-Unis] | Levodopa/dopamine replacement strategies in Parkinson's disease—Future directions |
| 001235 | Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lled [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne] | Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study |
| 001365 | Vesna Sossi ; Rau L De La Fuente-Ferna Ndez [Espagne] ; Michael Schulzer ; John Adams [Canada] ; Jon Stoessl | Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications |
| 001427 | Leo Verhagen Metman [États-Unis] ; Shaun T. O'Leary [États-Unis] | Role of surgery in the treatment of motor complications |
| 001450 | Cheryl Waters [États-Unis] | Other pharmacological treatments for motor complications and dyskinesias |
| 001455 | Charles H. Adler [États-Unis] | Nonmotor complications in Parkinson's disease |
| 001458 | C. Warren Olanow [États-Unis] ; Joseph Jankovic [États-Unis] | Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis‐targeted, disease‐modifying strategy |
| 001464 | Joseph Jankovic [États-Unis] | Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations |
| 001480 | Stéphane Chapuis [France] ; Lemlih Ouchchane [France] ; Olivier Metz [France] ; Laurent Gerbaud [France] ; Franck Durif [France] | Impact of the motor complications of Parkinson's disease on the quality of life |
| 001530 | L. Alvarez ; R. Macias ; G. Lopez ; E. Alvarez ; N. Pavon ; M. C. Rodriguez-Oroz ; J. L. Juncos ; C. Maragoto ; J. Guridi ; I. Litvan ; E. S. Tolosa ; W. Koller [États-Unis] ; J. Vitek ; M. R. Delong ; J. A. Obeso | Bilateral subthalamotomy in Parkinson's disease: initial and long-term response |
| 001582 | Gurutz Linazasoro [Espagne] | Recent failures of new potential symptomatic treatments for parkinson's disease: Causes and solutions |
| 001822 | V. S. Kosti ; J. Marinkovi ; M. Svetel ; E. Stefanova ; S. Przedborski [États-Unis] | The effect of stage of Parkinson’s disease at the onset of levodopa therapy on development of motor complications |
| This area was generated with Dilib version V0.6.23. |  |